News

Partner companies' news

KemPharm Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Corporate Updates
CELEBRATION, Fla., March 30, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a specialty pharmaceutical company...
Acorn Management Partners, Administrator
— April 2022 — 454 views KMPH

Motorsport Games Reports Fourth Quarter & Full Year 2021 Financial Results
MIAMI, March 30, 2022 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games” or the “Company”) today reported financial result...
Acorn Management Partners, Administrator
— April 2022 — 467 views MSGM

Motorsport Games’ rFactor 2 Becomes the Official Sim Racing Platform of Formula E
MIAMI, March 28, 2022 (GLOBE NEWSWIRE) -- None [1]*Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games”)* , a leading racing game developer, pub...
Acorn Management Partners, Administrator
— March 2022 — 501 views MSGM

Motorsport Games Partners with Romain Grosjean to Assist in the Development of rFactor 2 and esports Events
MIAMI, March 25, 2022 (GLOBE NEWSWIRE) -- None [1]*Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games”)* , a leading racing game developer, pub...
Acorn Management Partners, Administrator
— March 2022 — 461 views MSGM

KemPharm to Participate in Maxim’s 2022 Virtual Growth Conference
CELEBRATION, Fla., March 24, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery a...
Acorn Management Partners, Administrator
— March 2022 — 477 views KMPH

KemPharm Announces Full Data Set from Higher-Dose Serdexmethylphenidate (SDX) Phase 1 Clinical Trial
CELEBRATION, Fla., March 21, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (the Company or KemPharm), a specialty pharmaceutical company ...
Acorn Management Partners, Administrator
— March 2022 — 455 views KMPH

Motorsport Games to Report Fourth Quarter & Full Year 2021 Financial Results
MIAMI, March 16, 2022 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games”), a leading racing game developer, publisher and ...
Acorn Management Partners, Administrator
— March 2022 — 405 views MSGM

KemPharm Earns $1.975 Million Fee from Corium Following FDA Approval of the Corium Product ADLARITY® (donepezil transdermal system)
CELEBRATION, Fla., March 16, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (the Company, or KemPharm), a specialty pharmaceutical company...
Acorn Management Partners, Administrator
— March 2022 — 433 views KMPH

KemPharm to Report Fourth Quarter and Full-Year 2021 Results
CELEBRATION, Fla., March 10, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery a...
Acorn Management Partners, Administrator
— March 2022 — 477 views KMPH

KemPharm Completes KP1077 Pre-IND Meeting Process with FDA
CELEBRATION, Fla., Feb. 23, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery an...
Acorn Management Partners, Administrator
— February 2022 — 462 views KMPH

Motorsport Games Announces Next Gen Car For NASCAR 21: Ignition
MIAMI, Feb. 15, 2022 (GLOBE NEWSWIRE) -- None [1]*Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games”)* , a leading racing game developer, publ...
Acorn Management Partners, Administrator
— February 2022 — 491 views MSGM

Motorsport Games and Adam Breeden announce global agreement with Formula 1® to create next-level competitive socialising experience, launching in London in 2022
MIAMI, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Adam Breeden, the pioneer of competitive socialising in the UK and entrepreneurial force behind some of the...
Acorn Management Partners, Administrator
— February 2022 — 435 views MSGM

Motorsport Games Announces rFactor 2 Content Update and User Interface Refresh
MIAMI, Feb. 07, 2022 (GLOBE NEWSWIRE) -- None [1]*Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games”)* , a leading racing game developer, publ...
Acorn Management Partners, Administrator
— February 2022 — 432 views MSGM

KemPharm Issues Letter to Shareholders Detailing Strategic Focus on CNS/Rare Disease Indications and Updated Clinical Development Strategy
CELEBRATION, Fla., Jan. 19, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery an...
Acorn Management Partners, Administrator
— January 2022 — 446 views KMPH

KemPharm to Host Investor Conference Call Detailing Plans for Pipeline Expansion
CELEBRATION, Fla., Jan. 12, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery an...
Acorn Management Partners, Administrator
— January 2022 — 464 views KMPH

KemPharm Announces Research Involving Serdexmethylphenidate to be Featured in Two Poster Presentations at the APSARD 2022 Annual Conference
CELEBRATION, Fla., Jan. 11, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery an...
Acorn Management Partners, Administrator
— January 2022 — 454 views KMPH

Clinical Evaluation Finds Arch Therapeutics’ AC5® Advanced Wound System Effective in Healing Complex Chronic Wounds in Patients with Previously Unsuccessful Treatments and Significant Comorbidities
FRAMINGHAM, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“*Arch*” or the “*Company*”), a marketer and developer o...
Acorn Management Partners, Administrator
— January 2022 — 454 views ARTH

KemPharm to Participate in BIO Partnering @ JPM During “J.P. Morgan Week 2022”
CELEBRATION, Fla., Jan. 06, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery an...
Acorn Management Partners, Administrator
— January 2022 — 485 views KMPH

Arch Therapeutics Announces Appointment of Guy Fish to the Board
FRAMINGHAM, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“*Arch*” or the “*Company*”), a marketer and developer o...
Acorn Management Partners, Administrator
— January 2022 — 539 views ARTH

KemPharm, Inc. Announces Authorization of $50 Million Share Repurchase Program
CELEBRATION, Fla., Dec. 20, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery an...
Acorn Management Partners, Administrator
— December 2021 — 516 views KMPH

About us

Helping America invest in you:

Connecting your company stock with professional market participants.

One call at a time

Stay updated :

Participate on our social stream.

Our Blogs

Tags

Archives